Pivya

Indicated For

uncomplicated urinary tract infections

About This Medication

# Utility Therapeutics Pivya Patient Assistance Guide: How to Get Pivya at Low or No Cost Pivya (pivmecillinam) is an FDA-approved antibiotic for treating uncomplicated urinary tract infections (uUTIs) in adult women, and while Utility Therapeutics does not currently offer a dedicated manufacturer patient assistance program (PAP), independent foundations like the Patient Access Network (PAN) Foundation and HealthWell Foundation provide copay assistance to make it affordable.[2][5][6] ## About Pivya **Pivya** is a penicillin-class antibiotic that targets the bacterial cell wall, specifically effective against common uUTI-causing bacteria like *Escherichia coli*, *Proteus mirabilis*, and *Staphylococcus saprophyticus*.[5][6][7] Approved by the FDA in April 2024, it represents the first new antibiotic in about 20 years for this condition, with proven efficacy in three clinical trials showing better symptom relief and bacterial eradication than placebo, ibuprofen, or other treatments.[3][6][7] It's indicated for women 18 years and older with uncomplicated UTIs—meaning no fever, flank pain, or complications like kidney involvement.[5][6] Pivya has been used safely in Europe for over 40 years, with common side effects including nausea and diarrhea (occurring in ≥1% of patients).[5][7] It's expected to be available in U.S. pharmacies in Q4 2025, manufactured by Utility Therapeutics (recently acquired by Alembic Pharmaceuticals).[7] Always consult your doctor to confirm if Pivya is right for your infection, as it requires a prescription and susceptibility testing.[6] ## Who Qualifies for Assistance? Since no specific Utility Therapeutics PAP exists with defined income thresholds, eligibility focuses on copay programs from nonprofits like PAN and HealthWell.[2] These are designed for patients struggling with high out-of-pocket costs, regardless of insurance status (insured, uninsured, or underinsured). General criteria include: - U.S. residency and a valid prescription for Pivya. - Financial hardship, often based on household income at or below 400-500% of the Federal Poverty Level (FPL), though exact thresholds vary and should be verified on their sites. - Disease-specific funds (check if uUTI or Pivya is covered). PAN assists with copays/deductibles if Pivya is on their covered list; HealthWell offers similar support for high-cost meds.[2] NowPatient also provides free savings cards usable at 65,000+ pharmacies, potentially reducing costs by up to 90% or to $0 per fill.[2] ## Income Eligibility Breakdown Independent PAPs like PAN and HealthWell typically use FPL guidelines. Here's a general 2026 table for a household of 4 at common eligibility levels (verify current FPL on foundation sites, as they adjust annually): | Household Size | 400% FPL (e.g., PAN/HealthWell approx.) | 500% FPL (Higher threshold example) | |----------------|---------------------------------------|-------------------------------------| | 1 person | $60,240 | $75,300 | | 2 people | $81,760 | $102,200 | | 3 people | $103,280 | $129,100 | | 4 people | $124,800 | $156,000 | *Notes: Eligibility isn't strictly income-based; factors like copay amounts, diagnosis, and insurance play a role. No manufacturer program details available, so contact foundations directly.[2]* ## Insurance Requirements Most copay programs require commercial insurance but exclude government plans like Medicare, Medicaid, or VA.[2] However: - **Insured patients**: Eligible for copay cards/savings if copays exceed $50-100/month. - **Uninsured/underinsured**: May qualify for free/discounted meds via foundations or pharmacy coupons.[2] - **Medicare**: Typically ineligible for copay aid; explore Extra Help or state programs instead. Check PAN/HealthWell websites for Pivya-specific rules, as coverage can change.[2] ## Step-by-Step Application Process 1. **Confirm Eligibility**: Visit PAN Foundation (panfoundation.org) or HealthWell (healthwellfoundation.org) to search for Pivya. Use NowPatient.com for instant savings cards.[2] 2. **Gather Documents**: Prescription, proof of income (tax returns, pay stubs), insurance card (if applicable), and doctor's statement of medical necessity.[2] 3. **Apply Online/Phone**: Submit via foundation websites or call (PAN: 1-866-316-7263; HealthWell: 1-800-675-8416). NowPatient offers digital coupons—no application needed.[2] 4. **Doctor Involvement**: Your prescriber may need to complete sections confirming diagnosis and treatment need. 5. **Approval Wait**: 1-2 weeks typically; some instant for coupons.[2] 6. **Receive Assistance**: Copay card mailed/emailed, or grant applied to pharmacy. For manufacturer inquiries, contact Utility Therapeutics via pivya.com (no dedicated PAP listed).[5] ## Timeline and Delivery - **Processing**: Foundation grants: 5-14 business days; savings cards: immediate download.[2] - **Delivery**: Fill at any participating pharmacy (e.g., CVS, Walgreens). No special delivery; standard prescription pickup. Refills coordinated via your pharmacy/doctor.[2] - **Supply Duration**: Often 1-3 months per approval, with reapplication possible. ## Alternatives if Denied or Ineligible - **Pharmacy Coupons**: NowPatient or GoodRx for up to 90% off.[2] - **Other Foundations**: Check CancerCare, NeedyMeds, or RxAssist.org for UTI/antibiotic funds. - **Generic Options**: No generics yet; alternatives like nitrofurantoin or trimethoprim (per doctor).[6] - **Manufacturer Contact**: Email Utility/Alembic for potential unlisted aid (no program confirmed).[7] - **State Programs**: Medicaid, 340B clinics, or free clinics for low-income uninsured. **No biosimilars available, as Pivya is a small-molecule antibiotic.[7]** ## Important Disclaimer This guide is for informational purposes only and not medical/financial advice. Assistance program details change; always verify on official sites. Pivya treats specific uUTIs—consult your healthcare provider for diagnosis, risks, and alternatives. Utility Therapeutics has no publicly listed PAP; reliance on third-party sources like PAN/HealthWell.[2][5] Word count: 1028.

Program information last verified: March 30, 2026